VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
PACSPACS Group, Inc.
$41.89$6.6B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksPACSP/E History

PACS logoPACS Group, Inc. (PACS) P/E Ratio History

Expensive

Trading at 34.3x vs 5Y avg 21.1x · 100th percentile · Material premium to history · Data 2024–2026

Current P/E (TTM)
34.3x
+63% vs 5Y avg
5Y Avg P/E
21.1x
Median 22.0x
5Y Percentile
100th
Upper end of range
PEG Ratio
N/A
5-Year P/E Range
34.3x
Min13.2xMedian22.0xMax32.5x
TTM EPS$1.50
Price$41.89
Earnings Yield2.91%
EPS Growth (1Y)221.1%
EPS Growth (5Y)N/A

Loading P/E history...

P/E Ratio Analysis

As of June 28, 2026, PACS Group, Inc. (PACS) trades at a price-to-earnings ratio of 34.3x, with a stock price of $41.89 and trailing twelve-month earnings per share of $1.50.

The current P/E is 63% above its 5-year average of 21.1x. Over the past five years, PACS's P/E has ranged from a low of 13.2x to a high of 32.5x, placing the current valuation at the 100th percentile of its historical range.

Compared to the Financial Services sector median P/E of 14.2x, PACS trades at a 142% premium to its sector peers. The sector includes 801 companies with P/E ratios ranging from 0.0x to 157.7x.

Relative to the broader market, PACS commands a significant premium over the S&P 500 median P/E of 25.3x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.

For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our PACS DCF Valuation Calculator →

Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.

PACS Cross-Benchmark Valuation

How does the current P/E compare to sector peers and the broader market?

vs. Financial Services
34.3vs14.2
+142%
Above Sector
vs. S&P 500
34.3vs25.3
+36%
Above Market
PEG Analysis
N/A
P/E ÷ EPS Growth
Based on 221% EPS growth (1Y)

PACS P/E vs Peers

Diversified financial services and alternatives peers sorted by market cap

CompanyMarket CapP/E RatioPEG RatioEPS Growth (1Y)
ENSG logoENSGThe Ensign Group, Inc.
$10B27.92.02+14%
NHC logoNHCNational HealthCare Corporation
$3B26.91.17+17%
ADUS logoADUSAddus HomeCare Corporation
$2B18.60.92Best+23%Best
SEM logoSEMSelect Medical Holdings Corporation
$2B14.0Lowest--29%
CHE logoCHEChemed Corporation
$6B25.2--7%
UNH logoUNHUnitedHealth Group Incorporated
$388B32.3--15%
HUM logoHUMHumana Inc.
$46B39.0--1%
CVS logoCVSCVS Health Corporation
$133B75.1--62%

Lower P/E can signal a discount or weaker growth expectations; PEG adds growth context.

PACS Historical P/E Data (2024–2026)

Quarterly P/E ratios calculated from closing price and TTM EPS

QuarterPeriod EndPriceTTM EPSP/E Ratiovs Avg
FY2026 Q1-$32.12$1.5121.3x+1%
FY2025 Q4Dec 31 2025$38.39$1.1832.5x+54%
FY2025 Q3-$13.73$1.0413.2x-37%
FY2025 Q2Jun 30 2025$12.92$0.8215.8x-25%
FY2025 Q1Mar 31 2025$11.24$0.4425.7x+22%
FY2024 Q4-$13.11$0.6022.0x+4%
FY2024 Q3Sep 30 2024$39.97$1.7522.9x+8%
FY2024 Q2Jun 30 2024$29.50$1.9015.6x-26%

Average P/E for displayed period: 21.1x

Export Data
Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

2+ years return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

PACS — Frequently Asked Questions

Quick answers to the most common questions about buying PACS stock.

What is PACS's P/E ratio?

PACS Group, Inc. (PACS) trailing twelve-month P/E ratio is 34.3x, based on TTM diluted EPS of $1.50. The 5-year average P/E is 21.1x and the historical range spans 13.2x to 32.5x.

Is PACS stock overvalued or undervalued?

PACS trades at 34.3x P/E, above its 5-year average of 21.1x. The 100th percentile ranking within the 13.2x–32.5x historical range indicates a premium to historical valuation.

Is PACS stock expensive?

Yes, PACS is expensive relative to its own history. The current P/E of 34.3x is above the 5-year average of 21.1x and also above the Financial Services sector median of 14.2x. The stock sits at the 100th percentile of its 5-year valuation range.

What is PACS's historical P/E range?

Over the past 5 years, PACS's P/E ratio has ranged from 13.2x to 32.5x, with a median of 22.0x and an average of 21.1x. The current P/E of 34.3x places the stock at the 100th percentile of this range. Full historical data spans 2024–2026.

How does PACS's P/E compare to the S&P 500?

PACS trades at 34.3x P/E versus the S&P 500 median of 25.3x. The 36% premium to the market typically reflects higher expected earnings growth or quality.

How does PACS's valuation compare to Financial Services peers?

PACS Group, Inc. P/E of 34.3x compares to the Financial Services sector median of 14.2x. The premium reflects expected growth above peers or stronger fundamentals. See the peer comparison table on this page for ticker-by-ticker P/E and PEG.

What is PACS's PEG ratio?

PACS PEG ratio is N/A, based on a P/E of 34.3x and EPS growth of 221.1%. PEG normalises P/E by growth and helps compare stocks with different earnings trajectories.

What is PACS's earnings yield?

PACS earnings yield is 2.91%, the inverse of its 34.3x P/E ratio. Earnings yield represents the percentage of each dollar invested that the company earns. It can be compared directly to bond yields to assess relative attractiveness of stocks versus fixed income.

PACS P/E Ratio History (2024–2026)

Quarterly valuation multiple from closing price and trailing EPS

Current21.3x
Period Avg21.1x
Range13.2x - 32.5x
Change+37%
8 quartersJun 30, 2024 - Mar 31, 2026